Iain Kilty: CEO of Sitryx

Portrait of Iain Kilty

Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service

1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending